Table 1. Demographic and clinical data on patients with glioblastoma multiforme.
| Variable | n | % |
|---|---|---|
| Gender: male female |
37 26 |
58.7 41.3 |
| Age group (years): ≤65 ≥66 |
28 35 |
44.4 55.6 |
| ECOG performance status (preoperative) 0 1 2 3 |
4 30 20 2 |
7.1 53.6 35.7 3.6 |
| Karnofsky index (preoperative) 50 60 70 80 90 100 |
2 0 20 18 12 4 |
3.6 0.0 35.7 32.1 21.4 7.1 |
| Tumor location: one lobe only two lobes multicentric |
21 34 4 |
35.6 57.6 6.8 |
| Type of surgery (resection): complete subtotal partial |
11 37 11 |
18.6 62.7 18.6 |
| Karnofsky index (postoperative): 50 60 70 80 90 100 |
3 0 16 18 8 2 |
6.4 0.0 34.0 38.3 17.0 4.3 |
| Postoperative treatment: radiotherapy chemotherapy |
52 44 |
82.5 73.3 |
| Type of chemotherapeutic agents: temozolomide alkylating nitrosourea compounds (CCNU, BCNU) PCV |
39 8 7 |
65.0 13.3 11.7 |
ECOG = Eastern Cooperative Oncology Group score; CCNU = lomustine; BCNU = carmustine; PCV = procarbazine, lomustine, vincristine